Clinical Trial

Prevalence of Abnormal Haemoglobin Variants in Metropolitan Chattogram, Bangladesh

Study acronym: Hb Variants
Completed
View on ClinicalTrials.gov →
Summary
Hemoglobinopathies are inherited disorders that affect haemoglobin and pose a considerable global health challenge. This research addresses the knowledge gap regarding the prevalence of a typical haemoglobin fraction within urban populations by testing the HbA1c test in capillary electrophoresis. Participants will be recruited with careful ethical considerations and informed consent will be obtained. The screening will utilize laboratory techniques to detect abnormal haemoglobin fractions through testing. Statistical methods will be used for data analysis to assess prevalence rates and pinpoint specific haemoglobin variants while considering demographic factors. The project's milestones include planning the study, collecting data (from January 2021 to June 2025), conducting analyses, preparing reports and sharing the findings.
Trial Details
NCT Number NCT07305181
Lead Sponsor Bangladesh Bioscience Research Group
Collaborators: Chattogram International Dental College, Chittagong Medical College and Hospital, Bangladesh Medical University
Conditions HbE Trait, Hemoglobinopathies
Enrollment 8,400 participants
Start Date 2021-01-01
Primary Completion 2025-06-30 (estimated)
Study Completion 2025-09-30 (estimated)
Updated on ClinicalTrials.gov 2025-12-26